12:00 AM
 | 
Jul 05, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Byetta exenatide regulatory update

CHMP issued a positive opinion to extend the indication for Byetta exenatide to include treatment of Type II diabetes in combination...

Read the full 84 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >